Sort
130,381 grants matching “hiv”
University of Puerto Rico Clinical Trials Unit
$2,397,451Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2012 · AI
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.
$2,396,894Robert Ernst · University Of Maryland Baltimore · N01 · FY2019 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,396,840Valerie Fremont · Quality Biological, Inc. · N01 · FY2019 · AI
Combination HIV Antiretroviral Rectal Microbicide Program
$2,396,779Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2011 · AI
HIV/AIDS Vaccine and Antibody Development
$2,396,730John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) - III
$2,395,477Bridget F Grant · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Targeting hepatitis B virus cccDNA during HBV/HIV co-infection
$2,395,056Alexander Ploss · Princeton University · R01 · FY2025 · AI
Human anti-viral immune responses in tissues and circulation
$2,394,560Donna L Farber · Columbia University Health Sciences · U19 · FY2021 · AI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa
$2,394,527Diane V Havlir · University Of California, San Francisco · P01 · FY2009 · HD
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,394,432Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2013 · HL
Case Clinical Trials Unit
$2,393,908Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2024 · AI
IMMUNE EPITOPE AND ANALYSIS PROGRAM: Infectious Diseases
$2,393,779Stephen Wilson · La Jolla Institute For Immunology · N01 · FY2024 · AI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa
$2,393,553Diane V Havlir · University Of California, San Francisco · P01 · FY2011 · HD
Expansion of Mail-Delivered Harm Reduction Services in the U.S.
$2,393,373Czarina Navos Behrends · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DA
Anti-viral immune responses in lymph node
$2,393,299Ulrich H Von Andrian · Harvard Medical School · P01 · FY2011 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$2,392,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,391,459University Of North Carolina Chapel Hill · U01 · FY2001 · AI
Interferon-modulated vaccines against HIV
$2,391,250Pablo Penaloza · Northwestern University At Chicago · DP2 · FY2020 · DA
GENERAL CLINICAL RESEARCH CENTER
$2,390,953University Of Texas Medical Br Galveston · M01 · FY2003 · RR
Administrative Core
$2,390,793Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · GM
Northwestern University Clinical Trial Unit
$2,390,396Robert L. Murphy · Northwestern University At Chicago · U01 · FY2007 · AI
NIAID Preclinical Development Support
$2,390,291Phillip Ishikawa · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
A NOVEL VEE REPLICON VACCINE FOR HIV
$2,389,569University Of North Carolina Chapel Hill · P01 · FY2000 · AI
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
$2,389,457Michael Marcel Lederman · Case Western Reserve University · P01 · FY2009 · AI
Anti-viral immune responses in lymph node
$2,389,184Ulrich H Von Andrian · Harvard Medical School · P01 · FY2010 · AI